A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-38877618 in Healthy Male Participants
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety, tolerability, pharmacokinetics, and
pharmacodynamic effects of single oral doses and multiple oral doses of JNJ-38877618
administered for 7 consecutive days in healthy adult male participants.